These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 14608905
1. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. Browne P, Petrosyan K, Hernandez A, Chan JA. Am J Clin Pathol; 2003 Nov; 120(5):767-77. PubMed ID: 14608905 [Abstract] [Full Text] [Related]
2. Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma. García-Cosío M, Santón A, Martín P, Camarasa N, Montalbán C, García JF, Bellas C. Mod Pathol; 2004 Dec; 17(12):1531-8. PubMed ID: 15257313 [Abstract] [Full Text] [Related]
3. B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma. Herbeck R, Teodorescu Brînzeu D, Giubelan M, Lazăr E, Dema A, Ioniţă H. Rom J Morphol Embryol; 2011 Dec; 52(1):69-74. PubMed ID: 21424034 [Abstract] [Full Text] [Related]
4. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Moore EM, Swerdlow SH, Gibson SE. Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661 [Abstract] [Full Text] [Related]
12. Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators. Cho RJ, McCalmont TH, Ai WZ, Fox LP, Treseler P, Pincus LB. J Cutan Pathol; 2012 Jun; 39(6):651-8. PubMed ID: 22324490 [Abstract] [Full Text] [Related]
13. Lineage determination of CD20- B-Cell neoplasms: an immunohistochemical study. Chu PG, Loera S, Huang Q, Weiss LM. Am J Clin Pathol; 2006 Oct; 126(4):534-44. PubMed ID: 16938666 [Abstract] [Full Text] [Related]
18. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma]. Liu YH, Zhuang HG, Lin HL, Wu QL, Luo DL, Li L, Luo XL. Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292 [Abstract] [Full Text] [Related]
20. Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases. Tzankov A, Zimpfer A, Pehrs AC, Lugli A, Went P, Maurer R, Pileri S, Dirnhofer S. Mod Pathol; 2003 Nov; 16(11):1141-7. PubMed ID: 14614054 [Abstract] [Full Text] [Related] Page: [Next] [New Search]